CBLL1 and cancer: Given that proinflammatory cytokines, such as interferons (IFNγ), can enhance the immune system’s ability to recognize and kill cancer cells by activating cytotoxic T cells and natural killer (NK) cells, this opens a new important field of investigation regarding the potential role of Hakai in the tumor microenvironment.